Pharma R&D Today

Ideas and Insight supporting all stages of Drug Discovery & Development

Select category
Search this blog

admin

About the author:

Posts by admin

Predictive Analytics Help Identify Drug Candidate Molecules

Posted on January 26th, 2019 in Pharma R&D

The process of discovering a viable drug candidate molecule is often time-consuming and research-intensive. A lab must test thousands of compounds every day — and a hit rate of just 1 percent is considered above average.

(more…)

Growth, recognition, results—and an important partnership

Posted on January 17th, 2019 in Pharma R&D

Here at Sigilon Therapeutics, we have had a very exciting period of growth recently, including receiving an Advanced Therapy Medicinal Product (ATMP) designation from the European Medicines Agency, adding two new members to our leadership team and initiating a collaboration with Eli Lilly in type 1 diabetes. (more…)

Avoiding Pitfalls and Costly Mistakes in Early Stage R&D

Posted on January 17th, 2019 in Pharma R&D

Pharma R&D costs continue to rise rapidly. A well-known Tufts study estimated the average pre-tax cost per new approved prescription drug (including failures and capital costs) was nearly $2.6 billion in 2013. However, the creation of novel approved drugs has not kept up with investment over the past two decades. (more…)

Pharma and Biotech Firms Gather at the 37th Annual J.P. Morgan Healthcare Conference

Posted on January 15th, 2019 in Pharma R&D

2019 marks the 37th year of the J.P. Morgan Healthcare Conference, which has come to be one of the premiere annual events for companies involved in all aspects of the industry, from biotech start-ups to large healthcare service providers. (more…)

  1. 1
  2. 2